Corleen Roche
Directeur Financier/CFO chez CG ONCOLOGY, INC.
Fortune : 72 400 $ au 30/04/2024
Profil
Corleen M.
Roche is currently the Chief Financial Officer, CAO & Secretary at CG Oncology, Inc. She previously held positions as the Chief Financial Officer-US at Biogen, Inc., the Chief Financial Officer at Sandoz, Inc., the Chief Financial & Accounting Officer at Immunome, Inc., the Chief Financial Officer at Iogenetics LLC, and the Chief Financial Officer at Wyeth Pharmaceuticals, Inc. Ms. Roche obtained her undergraduate degree from Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0,00% | 29/01/2024 | 2 000 ( 0,00% ) | 72 400 $ | 30/04/2024 |
IMMUNOME, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Corleen Roche
| Sociétés | Poste | Début |
|---|---|---|
| CG ONCOLOGY, INC. | Directeur Financier/CFO | 01/01/2024 |
Anciens postes connus de Corleen Roche
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOME, INC. | Directeur Financier/CFO | 02/01/2024 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Directeur Financier/CFO | - |
| Iogenetics LLC | Directeur Financier/CFO | - |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Directeur Financier/CFO | - |
| BIOGEN INC. | Directeur Financier/CFO | - |
Formation de Corleen Roche
| Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
| Iogenetics LLC | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |